A Novel Reversed Phase High Performance Liquid Chromatography Method To Accurately Determine Low Concentrations Of Curcumin In Rat Plasma by Setyaningsih, Dewi
Available online at www.ijpcr.com 
International Journal of Pharmaceutical and Clinical Research 2016; 8(5)Suppl: 377-386 
International Conference on Pharmacy and Advanced Pharmaceutical Sciences (ICPAPS 2015) 
Faculty of Pharmacy, Universitas Gadjah Mada 
     
                                                                                                                       ISSN- 0975 1556 
Conference Proceedings 
 
*Author for Correspondence Email: fudholi_apt@ugm.ac.id; dewisetya03@yahoo.com 
A Novel Reversed Phase High Performance Liquid Chromatography 
Method To Accurately Determine Low Concentrations Of Curcumin In 
Rat Plasma 
 
Setyaningsih D1,2*, Murti YB2, Martono S2, Hinrichs W.L.J.3, Hertiani T2, Fudholi A2 
 
1Faculty of Pharmacy, Sanata Dharma University, Yogyakarta, Indonesia 
2Faculty of Pharmacy Gadjah Mada, University, Yogyakarta, Indonesia 
3Department of Pharmaceutical Technology and Biopharmacy, University of Groningen, The Netherlands 
 
ABSTRACT 
Due to its lipophilic nature, curcumin levels in plasma are very low after oral administration, and therefore hard to detect. 
A number of chromatographic methods, including LC/MS have been developed. Although the LC/MS method is sensitive, 
the matrix effect can be difficult to handle. Furthermore, LC/MS equipment is relatively expensive compared to the 
conventional RP-HPLC. Therefore, the aim of this study was to develop a sensitive and reliable method for the 
determination of curcumin concentration in plasma using an RP-HPLC. Curcuma longa extract was used which contains 
three curcuminoids. The method started by selection of mobile phase to optimally separate the curcuminoids. The best 
mobile phase composition was used to analyze the plasma samples. Rat plasma was spiked with curcumin and processed 
for protein precipitation followed by liquid-liquid extraction of curcuminoids and an internal standard, emodin. 
Chromatogaphic separation of curcuminoids and emodin was achieved using a Knauer C-18 column (250 x 4.6 mm; 
particle size: 5µm) and a gradient program of mobile phase of three solvents, methanol-acetonitrile-1% acetic acid. A 
gradient elution was applied with increasing the ratio of the volume percentages of acetonitrile to acetic acid from 50/45 
to 53/42 during 5 minute and thereafter elution was isocratic for 15 minute. The methanol concentration was kept constant 
at 5 vol-% during the whole run. The method was validated according to the FDA guidelines.The method was selective, 
with an excellent resolution (Rs value > 2.5). The peak shape of both curcumin and emodin were symmetric with a tailing 
factor of 0.9-1.1. The method linearity (correlation coefficient of 0.999) was demonstrated at 6 to 200 ng/mL. The intra- 
and inter-day precision was 5.90-8.50% and 5.37-11.26%, respectively; the intra- and inter-day accuracy was 92.47-
103.61% and 96.17-105.70%, respectively. In conclusion, the RP-HPLC method meets the validation requirements as 
described in the FDA guidelines and is applicable to accurately quantify curcumin concentrations as low as 6 ng/mL in rat 
plasma samples. 
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INTRODUCTION 
Curcumin [1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-
heptadiene-3,5-dione] is the active ingredient of turmeric 
(Curcuma longa L), a food spice and colorant widely used 
in South-eastern Asia. Since the ancient time, turmeric has 
been used as an important part of JAMU1, a traditional 
Indonesia medicine from plants. As a part of the JAMU, in 
folk medicine turmeric has been used for curing and 
preventing many ailments like liver disease, digestion 
problem and dysmenorrhoea. Curcumin, the active 
constituent of turmeric, has been reviewed to have a 
variety of biological activities and pharmacological 
actions, such as anti-tumor, anti-inflammatory, anti-virus, 
anti-oxidation, anti-HIV and hepatoprotective2. Being 
granted as a Generally Recognized As Safe (GRAS) 
compound by the Unites State Food and Drug 
Administration, together with the many beneficial 
activities, the exploration of this compound are enormous, 
thus makes curcumin to be highly potential use in clinical 
applications. Despite the extraordinary benefits, curcumin 
concentration in systemic circulation after oral intake was 
reported to be very low. A study by Wahlstrom and 
Blennow in Sprague-Dawley rats reported that 75% of 
curcumin was found in the faeces, while negligible amount 
was appeared in the urine and plasma after oral 
administration of the dose of 1g/kg curcumin3. Another 
study revealed that 1 h after a single oral dose of 1 g/kg, 
the curcumin concentration in rat plasma was lower than 
20 ng/ml3. In a human study, the maximum plasma level 
of curcumin was only 11 ng/mL following oral 
administration of 2 g curcuminoids containing 85% 
curcumin, and 1 hour later no curcumin levels could be 
detected at all4, indicating rapid clearance from the body. 
The low curcumin concentration can be ascribed to its poor 
absorption due to its low aqueous solubility (11 ng/mL)5 
with a calculated logP of 4.12 (by a default setting of  
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ChemAxon 5.2.5.1). Besides being poorly absorbed, the 
low plasma concentration of curcumin is also attributed to 
the extensive biotransformation, which has been reported 
to occur in the intestinal tissue, liver, and kidney.  
Metabolic studies in rats and mice demonstrated that 
curcumin glucuronate and curcumin sulfate are the major 
metabolites6,7. The low curcumin concentration found in 
the systemic circulation demands an assay with a  
sufficiently high sensitivity. It has been suggested that 
ability of a method to reliably quantify curcumin 
concentrations below 10 ng/ml is necessary for a better 
characterization and understanding the fate of curcumin in  
the body8. Several Reverse Phase High Performance 
Liquid Chromatography (RP-HPLC) methods have been 
developed to response to the need of a reliable and highly  
sensitive method for curcumin determination in biological 
samples. In various studies HPLC UV-Visible detection 
was used to analyze curcumin in the plasma samples of 
rats. However, in most of them a lower limit of 
quantification (LLOQ) below 15 ng/mL was not reached9-
11. Although it was expected that to be more sensitive than 
a UV-Visible detector, the HPLC analysis using a 
fluorescent detector as performed by Schiborr et al. did not 
improve the method sensitivity as the detection limit was 
20 ng/mL12. In a few studies, however, an LLOQ below 
the suggested value of 10 ng/mL obtained by HPLC UV-
Visible detection was found. Disadvantages of these 
methods are that a quite high sample injection volume of 
50 µL is required13 or that it requires longer analysis time 
(ca 50 minutes) than the methods described above14. An  
attempt to achieve a more sensitive method, the use of an 
HPLC employing a mass spectrophotometer detector (LC-
MS) has been explored. In two studies an LLOQ value of 
0.5 ng/mL has been found15,16. Although the LC-MS 
method have been reported to have a satisfied sensitivity 
and selectivity with a significant reduced analysis time 
compared to the conventional HPLC, the equipments are 
relatively expensive and the effects of the matrix are not 
easy to handle17. In this study, we developed an RP-HPLC 
UV-Visible method using gradient system that produced 
reasonable separation and sensitivity and was validated 
according to the FDA guidelines for bioanalysis. In this 
developed method, curcumin concentration as low as 6 
ng/mL was able to be accurately quantified with 
satisfactory chromatogram properties. The lower limit of 
detection was even 0.5 ng/mL while keeping the injection 
volume small (20 µL). In addition, compared to the method 
developed by Ireson et al.14, and Li et al.13, the developed 
method allows a substantial reduction of analysis time (ca 
20 min). 
 
MATERIALS AND METHODS 
Chemicals and reagents. Curcumin as the standard 
compound was purchased from Nacalai, Japan. C. longa 
extract was a kind gift from PT Phytochemindo Reksa,  
Bogor, Indonesia. It is well known that C. longa extract is 
composed of a mixture of three curcuminoids, namely: 
curcumin, demethoxycurcumin, and bis-
demethoxycurcumin18. HPLC mesurements operated 
using the method developed in this study indicated that the 
curcumin content of the extract was 67.9%. Emodin which 
was used as an internal standard compound was purchased 
from Sigma. Solid dispersion of composed of C. longa 
incorporated in a matrix of polyvinylpyrrolidone K30 
(PVP K30) was prepared by drying an ethanolic solution 
of both components using a rotary evaporator. HPLC grade 
of acetonitrile and methanol were obtained from Merck, 
Darmstadt, Germany. Analytical grade glacial acetic acid 
and ethyl acetate were purchased from Merck, Darmstadt, 
Germany. Water was used as ultra pure water, which was 
prepared using a Milli-Q water purifier. 
Equipment 
The analysis was carried out using a 2010 HT Shimadzu 
HPLC (Kyoto, Japan) consisting of a serial dual plunger 
pump, an autosampler, and a UV detector. The HPLC was 
connected to a computer with LC-solution software.  
Wavelength detection 
Wavelength selection was carried out using a 
spectrophotometer (Shimadzu, Japan). A methanolic 
solution of curcumin was prepared at a concentration of 
2.5 µg/mL. The solutions were scanned at a wavelength 
range of 200 – 600 nm. 
Chromatographic condition 
The chromatographic separation was carried out on a 
Knauer C18 column (250 x 4.6 mm) equipped with a 
precolumn (Dr. Ing. Herbert Knauer, Berlin, Germany). 
The packing material was Eurospher 100 with 5µm 
particle size. The injection volume was 20 µL and the flow 
rate was 1.0 mL/min. The column oven was set at a 
temperature of 30°C. The UV-detection was based on the 
wavelength scanning experiment.  
Mobile phase optimization 
The selection of mobile phase was based on literature19,9,20 
in which the separation of the three curcuminoids from the 
methanolic solution of C. longa extract by HPLC was 
reported. A volume of 20 µL was injected onto the HPLC 
column. The peaks resulted from elution of that mobile 
phase were compared and the quality of the 
chromatographic separation, i.e. tailing factor (T), peak 
resolution (Rs), and theoretical plate number (N) were 
determined using the LC-solution software. The 
recommended limits of these chromatography parameters 
are T<1.5, Rs>2.0, and N>200021,22. The optimized HPLC 
system was tested on the chromatographic separation of 
extracted rat plasma sample taken at 15 minutes following 
oral administration of a PVP based solid dispersion 
formulation containing C. longa extract (20 mg/kg BW). 
This pilot animal experiment was approved by the Medical 
and Health Research Ethics Committee (MHREC) 
number: KE/FK/5/2/EC continued to KE/FK/512/EC year 
2013. The plasma samples were processed according to the 
described method in the section “sample preparation” of 
this manuscript and analyzed using the optimized HPLC 
system. The chromatogram quality was determined by 
assessment of T, Rs, and N. 
Stock solution, calibration samples and quality control 
samples 
Stock solutions of curcumin and emodin as the internal 
standard (IS) were prepared separately in methanol at 
concentrations of 950 µg/mL and 1.2 mg/mL, respectively. 
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The stock solution of curcumin was diluted with methanol 
to prepare working stock solutions of 0.06, 0.125, 0.25, 
0.5, 1.0, and 2.0 µg/mL. Series of concentrations of the 
calibration samples were prepared by spiking of 10 µL of 
each working stock solution into 90 µL blank plasma 
samples. Using a similar spiking technique to that of 
calibration samples, control samples as quality control (QC 
samples) were prepared at a concentration of 20, 50 and 
100 ng/mL for precision and accuracy studies. Another set 
of QC samples for the stability studies were prepared at 
aconcentration of 20 and 100 ng/mL. The QC samples 
were kept at -20°C and were brought to room temperature 
before analysis. The stock solutions were stored at-20°C 
for the maximum of 3 weeks23. During sample preparation, 
the samples were properly shielded from light to prevent 
photodegradation of curcumin24. 
Sample preparation 
IS stock solution of emodin was diluted with methanol to 
prepare a working stock solution at the concentration of 
5.95 µg/mL. The frozen samples were thawed at room 
temperature. After thawed completely, the samples were 
vortexed for 20 sec. To 100 µL of sample, 10 µL of 
working stock solution of IS was added. Then, 20 µL of 
2% acetic acid and 400 µL of acetonitrile was added to 
induce protein precipitation. The resulting mixture was 
vortexed for 20 sec. A volume of 1000 µL extraction  
medium, which consisted of 95 vol-% ethyl acetate and 5 
vol-% methanol11, was added to the sample. The mixture 
was vortexed for 2 minutes to extract the curcumin. After  
centrifugation at 1000 rpm for 20 min, the supernatant was 
removed quantitatively and transferred into 5 mL tubes. 
The solvent was then allowed to fully evaporate under 
nitrogen stream at the temperature of 40 °C. The dried 
samples were reconstituted with 100 µL methanol. To 
remove any undissolved substances the sample was 
centrifuged at 8000 rpm for 20 minutes after which the 
supernatant was taken. The supernatants were transferred 
into the inserts of the HPLC amber vials and an aliquot of  
20 µL was injected onto the HPLC column. The nominal 
concentrations of the calibration series were 6, 12.5, 25, 
50, 100, and 200 ng/mL curcumin and 0.595 µg/mL 
emodin.  
Bioanalytical method validation 
Validation was carried out to evaluate the HPLC method 
for the quantification of curcumin in the plasma samples. 
The validation procedures were according to the Food 
Drug Administration (FDA) guidelines for bioanalytical 
method validation25. The basic parameters for 
bioanalytical method validation, i.e. selectivity, accuracy, 
precision, sensitivity, and stability, were evaluated. 
Additionally, the system suitability, extraction effectivity, 
and robustness were also investigated.   
System suitability test 
System suitability was assessed by conducting six replicate 
injections of a 1.8 µg/mL solution of curcumin in methanol 
and run under the optimized chromatographic conditions. 
The peak areas and the retention times were determined 
and their RSDs were calculated. An RSD value below 2% 
is acceptable21.  
Selectivity 
Selectivity is the ability of a method to discriminate 
between the analyte (curcumin) and other compounds 
present in the sample matrix. For the selectivity study, 
blank plasma samples originated from six different rats 
were analyzed. Plasma samples spiked with 6 ng/mL 
curcumin standard solution and 595 ng/mL IS solution 
were also analyzed. Plasma samples spiked with curcumin 
at the LLOQ concentration were used in the selectivity 
study. Selectivity was confirmed by comparing the 
chromatograms of spiked plasma samples with those of 
blank plasma samples. 
Extraction effectivity  
To determine extraction effectivity of the method, a set of 
samples with 5 replications for each concentration, low 
and high levels26, were prepared by spiking curcumin 
working solutions (10 µL) into 90 µL blank plasma 
samples resulted the sample concentrations of 20 and 100 
ng/mL. Each sample was supplemented with IS solution to 
achieve a final emodin concentration of 0.595µg/mL. 
Curcumin and and emodin were subsequently extracted 
from the samples using the method described above. In a 
control experiment, a set of blank plasma samples were 
prepared and subjected to the extraction procedure without 
the samples being supplemented with curcumin and IS 
solution. After completion of the extraction procedure, the 
control samples were spiked with curcumin and IS 
solutions at same concentration and volumes that were 
found in the pre-extraction spiked samples.The samples 
were treated as described in section “sample preparation” 
of this manuscript and injected into the HPLC column. 
Extraction effectivity for curcumin and IS was determined 
by calculating the ratios of the peak areas of the pre-
extraction spiked samples to those of samples spiked after 
extraction multiplied by 100 to obtain the effectivity in 
%26,27.  
Calibration curve and linearity 
A calibration curve was generated using curcumin 
solutions of six different concentrations with three 
replications for each concentration. The peak area ratios of 
curcumin to IS were plotted against the nominal 
concentrations of curcumin. A least-square regression 
analysis was used to calculate the regression equation and 
correlation coefficient. According to the FDA guidelines25, 
the linearity of the calibration curve is justified by the 
value of correlation coefficient (r) of at least 0.995. 
Furthermore, each back calculated concentration in the 
calibration curve was determined and should meet the 
requirement of ±15% deviation from the nominal value for 
at least four out of six nonzero concentrations of standards. 
The lower limit of quantification (LLOQ) was determined 
by evaluation of the precision and accuracy at the lowest 
concentration of the calibration samples which should 
have a precision of less than 20% relative standard 
deviation (RSD) and an accuracy of 80-120%25,26. The 
carry-over was determined by analysis of the highest 
curcumin concentration in the calibration samples. The 
carry-over experiment demonstrated no signals appeared 
around the retention time of curcumin or emodin, 
indicating no carry-over was observed using the optimized 
HPLC system.  
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Precision and accuracy 
Intra-day and inter-day precision and accuracy were 
determined using blank plasma samples spiked with 
curcumin solutions of three different concentrations with 5 
replications of each concentration (QC samples). The 
concentration levels were considered as low, medium, and 
high, which were 20, 50, and 100 ng/mL, respectively. The 
curcumin concentrations were obtained by calculating the 
ratios of curcumin peak area to that of IS and plotting it on 
the calibration curve. Precision was determined as a 
percentage relative standard deviation (RSD), while 
accuracy was assessed by the percentage of the found 
concentration to the nominal concentration. The precision 
determined at each concentration level should not exceed 
15% of RSD, except for the LLOQ, where it should not 
exceed 20% of RSD. The method is considered to be 
accurate when the mean value is within 15% of the actual 
value, except at the lower limit of quantification (LLOQ), 
where it should not deviate by more than 20%. 
Stability experiment 
The stability of curcumin in the plasma samples was 
investigated after three freeze thawing cycles, storage at- 
20°C for 10 days, and storage at ambient conditions for 4 
hours. In addition, the stability of the reconstituted sample 
(thus a solution in methanol) was determined during the 
period of time the sample was placed in the autosampler of 
HPLC (which was at ambient conditions) before the actual 
measurement. Freeze-thaw stability was evaluated by 
thawing the plasma samples spiked with curcumin at both 
low and high levels (20 and 100 ng/mL) at room 
temperature and then refreezing them to be frozen for 24 
hours at -20°C. This procedure was repeated three times 
after which the samples were analyzed. The 10 days 
stability study was conducted using plasma samples with 
curcumin concentrations of 20 and 100 ng/mL (QC 
samples). To ensure that curcumin was not degraded in the 
plasma sample during sample preparation including the 
sample extraction procedure, samples of 20 and 100 ng/mL 
curcumin were thawed and left unassisted for 4 hours 
under ambient conditions (22±2°C). After three freeze 
thawing cycles, or storage at -20°C for 10 days,or ambient 
conditions for 4 hours, the samples were prepared for and 
then analyzed by HPLC. The stability of the samples 
during the period of time they were maximally kept in the 
auto sampler before analysis was evaluated by reinjection 
of the reconstituted samples. Reconstituted samples 
containing 20, 50, and 200 ng/mL curcumin in methanol 
were reinjected after keeping them overnight in the HPLC 
autosampler at ambient conditions to mimic worse case 
conditions, i.e. to ensure the stability of the last sample in 
an analytical batch during the HPLC analysis (n=5 of each 
concentration level). The curcumin concentration of the 
samples subjected to the stability tests was calculated by 
plotting the ratios of the peak area of curcumin to the 
internal standard of the calibration curve, which was 
prepared on the day of analysis. RSD and accuracy were 
determined based on three replications of each 
concentration level. Samples are considered to be stable if 
the deviation of the observed concentration is within 15 % 
of the nominal value and the precision is below 15%25. 
Robustness 
The robustness of the HPLC method was challenged by 
applying a deliberate change to the operational parameters 
of the developed method. To study the robustness, a 
methanolic solution of curcumin standard was used at the 
concentration of 0.5µg/mL at an injection volume of 20 
µL. The changes applied to the parameters were the flow 
rate (0.6 and 0.8 mL/min), and the column oven 
temperature which was changed from 30°C to 26°C. The 
curcumin peak area resulted from the altered HPLC 
parameters were compared to the unaltered one. 
Robustness of the method was studied in triplicate. The 
RSDs of all collected data were calculated. The robustness 
is acceptable at RSD < 2%.   
 
RESULTS AND DISCUSSION 
Method development  
Wavelength selection. 
The wavelength detection for curcumin determination has 
been reported in the literature to be 420 nm [14, 13]. To be 
more accurate in the determination of curcumin, we 
conducted a wavelength scanning experiment of curcumin 
solution. The maximum absorption spectrum of curcumin 
solution in methanol was found to be 424 nm and thus, 
further analysis of curcumin was carried out at this 
wavelength. This analysis procedure involved the use of 
emodin as the internal standard compound, because there 
was an extraction method prior the determination of 
curcumin concentration. The use of IS is necessary as a 
correction factor for the loss of curcumin during sample 
preparation. Emodin was selected as the IS compound in 
this study because emodin and curcumin exhibits similar 
behavior with respect to extraction involving the solvents 
methanol, acetonitrile, and ethyl acetate, and water [13]. In 
addition to that, the peak of emodin was clearly observed 
at the wavelength used for curcumin determination (424 
nm).  
Selection of mobile phase.  
The goal of this study was to achieve an excellent 
resolution in the chromatographic separation of 
curcuminoids. Since the source of curcumin in our 
research was the curcuma extract obtained from C. longa 
plant, which contains besides curcumin also 
demethoxycurcumin and bisdemethoxycurcumin, an 
acceptable peak resolution of curcumin to the 
neighbouring curcuminoid peaks is required to provide an 
accurate determination of curcumin in the plasma sample. 
Therefore, selecting the HPLC system e.g. the eluent 
composition was necessary before conducting further 
experiments. The selection of mobile phase was based on 
literature20,19,9. Firstly, the mobile phase composed of 
acetonitrile – 1% acetic acid at 54:45 v/v19,9 was chosen to 
separate curcumin from the curcuminoids of the C. longa 
extract dissolved in methanol under the isocratic elution. 
The chromatographic condition using this eluent 
composition was unable to separate curcuminoids into 
three peaks; instead, only one peak was displayed in the 
chromatogram. This result indicates that the method failed 
to demonstrate the selectivity parameter of a method 
validation. Although the chromatogram showed a single  
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peak with a sharp and symmetrical shape with the tailing 
factor (T) of 1.01 and a theoretical plate number (N) of 
12449, which meets the recommendation limits (T <1.5; N 
≥ 2000)21,22  using this mobile phase composition leads to 
an inappropriate determination of curcumin in plasma 
sample when the sample contains two other curcuminoids  
as well. A perfect peak separation of the three 
curcuminoids was reported when a mixture of methanol  
 
Figure 1: Chromatogram of C.longa extract eluted using the optimized HPLC system; (a) C.longa extract in methanol 
(9 µg/mL).; (b) curcumin stock solution 0.9 µg/mL “C” represents curcumin. 
 
 
Figure 2: Chromatogram separation of curcumin in extracted plasma samples. (a) plasma sample taken at 15 minutes 
following oral administration of a PVP K30 based solid dispersion formulation containing C.longa extract. (b) 
curcumin standard solution (0.5 µg/mL); “C” and “E” represent curcumin and emodin, respectively. 
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Table 1: System suitability test of curcumin 
Injection Area Retention time (min) 
1. 332774 12.994 
2. 328770 12.979 
3. 337665 12.980 
4. 330586 12.890 
5. 332107 12.880 
6. 338280 12.849 
Average 333363.7 12.929 
SD     3831.86   0.063 
RSD           1.15   0.490 
 
and tetrahydrofuran (THF)28 was used as mobile phase. 
However, THF has some disadvantages, i.e. it strongly 
aborbs UV light, reacts with oxygen, displays slow column 
equilibration29, and causes swelling of polyether ether  
ketone resin, the constituent of most HPLC tubings30. 
Therefore, the use of THF in the mobile phase is not  
recommended in most HPLC systems31. An attempt to 
separate the three curcuminoids peaks by using a gradient 
elution program instead of isocratic elution program 
appeared to be successfull. The elution method was 
adapted from the work of Jayaprakasha et al.20, in which 
curcuminoids from different curcuma species were 
analyzed. In this study, the gradient program of the method 
was modified in order to be able to determine curcumin in 
a plasma sample which also contains other two 
curcuminoids and emodin as the internal standard.  C. 
longa extract in a methanolic solution was eluted with a 
mixture of methanol, acetonitrile, and 1% acetic acid 
aqueous solution (pH 3.5) using a gradient program. To 
optimize the method, different gradient programs were 
evaluated, i.e. the volume ratio of acetonitrile to 1% acetic 
acid aqeuous solution, flow rate, column oven temperature, 
and injection volume were varied. Chromatogram 
characteristics such as retention time, T, Rs, and N were 
determined using the LC-solution software. The optimal 
gradient mode was achieved by increasing the ratio of the 
volume percentages of acetonitrile to 1% acetic acid 
aqueous solution from 50/45 to 53/42 during 5 minute and 
thereafter isocratic elution for 15 minute. The methanol 
concentration was kept constant at 5 vol-% during the  
 
Figure 3: Representative of chromatogram of (a) blank plasma sample and (b) the plasma spiked with curcumin at the 
lower limit of quantification (6 ng/mL). “C” and “E” represent curcumin and emodin, respectively. 
 
Figure 4: A calibration curve for curcumin prepared in rat plasma (n=3). 
 
Setyaningsih et al. / A Novel Reversed ... 
 IJPCR, May 2016, Volume 8, Issue 5 Suppl. Page 383 
whole run. Another optimized parameters of the 
chromatographic separation of curcuminoids were 20 µL 
of injection volume, 1.0 mL/min of flow rate, and 30°C. of 
column oven temperature. The chromatogram of C. longa 
extract solution using this method displays three peaks 
with a sharp and narrow shape indicating an excellent 
separation of the three curcuminoids (Fig. 1a). In Fig. 1a, 
the peak appeared at a retention time of 12.91 minutes was  
confirmed as curcumin peak, according to the standard 
curcumin solution assayed in the same analytical batch  
 (Fig. 1b). The peak of curcumin was perfectly 
symmetrical in shape and separated from the neighbouring 
peaks with a T of 1.01 and an Rs of 2.64. The high 
theoretical plate number as demonstrated by a value of 
17294 indicates a high efficiency in the chromatographic 
separation. The optimized HPLC system was tested on an 
extracted plasma sample containing curcuminoids. The 
plasma was taken at 15 minutes following oral 
administration a PVP K30 based solid dispersion 
containing C.longa extract. The Fig 2a presents the 
chromatographic separation of the extracted plasma 
sample. The chromatographic separation as shown in Fig. 
2a displays an excellent peak separation of curcumin of the 
extracted plasma sample taken at 15 minutes after the rat 
was administered orally with the C.longa solid dispersion 
formulation. The optimized gradient system developed in 
this study was able to separate curcumin peak of the 
extracted plasma sample with a T of 0.97, Rs of 2.52, 
indicating a perfectly symmetrical peak and a satisfactory 
resolution. The retention time of the curcumin peak of the 
extracted plasma sample appeared consistently with that of 
the peak of curcumin standard solution (Fig. 2b). N of the  
extracted plasma sample (Fig. 2a) was 11991, which meets 
the recommendations limit of N > 2000. These data 
indicate an efficient chromatographic separation. To  
conclude, the developed analytical method is applicable to  
determine curcumin in plasma samples of rats which were  
administered orally with a formulation containing C.longa 
extract.  
Bioanalytical method validation 
System suitability test 
System suitability test is an integral part in the analytical 
method and used to confirm the adequacy of the operating 
system32. The optimized gradient mode was used to assess 
the HPLC system suitability. Six repetitive injections of 
curcumin standard solution of the same concentration were 
analyzed. The data resulted in RSD values of 1.15% for the 
peak area and 0.49 % for the retention time (Table 1). The 
both RSD values were below 2% indicating the suitability 
of the the method.  
Selectivity 
The selectivity study showed that compared to plasma 
samples spiked with curcumin (Fig. 3b), the extracted 
blank plasma sample (Fig. 3a) did not show any interfering 
peaks at the corresponding retention times of curcumin and 
emodin. This result confirms the selectivity of the 
developed method.  
Extraction effectivity 
The mean extraction effectivity for the plasma spiked 
samples of 20 and 100 ng/mL were 97.86 ±12.58 % and 
99.63±3.63 %, respectively. The extraction effectivity for 
the IS at the concentration of 0.595 µg/mL was 
96.96±2.96%. The results indicate that the extraction 
method was adequate for the quantification of curcumin 
levels in plasma samples.  
Calibration curve and linearity 
The calibration standard is presented in Fig. 4. The 
calibration standard was obtained using six series of 
plasma samples spiked with curcumin standard solution. 
Measurements were in triplicate. The calibration curve was 
constructed by plotting the ratio the peak area of curcumin 
to that of the IS (y-axis) against the nominal curcumin 
concentrations (x-axis). As can be observed in Fig 4, 
linearity was shown over the concentration range of 6-200 
ng/mL with the correlation coefficient (r) of 0.999, and the 
coefficient of determination (r2) of 0.998. The least square 
regression analysis resulted the regression equation of y = 
0.0046x + 0.0157. The back calculated concentrations 
based on the regression equation is presented in Table 2. 
Five out of six concentrations used to construct the 
calibration standard demonstrated below 15% deviation 
from the corresponding nominal values, which is within 
the range of the recommendation limits. The lowest 
concentration of the calibration series of 6 ng/mL was 
taken as the LLOQ value as the precision and accuracy  
Table 2: Precision and accuracy of alibration series 
after backcalculated from the regression equation 
(n=3) 
Nominal 
concentration 
(ng/mL) 
Mean 
calculated 
concentration 
(ng/mL) 
Precision 
(%) 
Accuracy 
(%) 
6.0 5.07 17.03 84.54 
12.5 14.11 10.83 112.85 
25.0 26.95 6.77 107.81 
50.0 49.94 3.42 99.89 
100.0 95.45 4.16 95.45 
200.0 201.97 1.06 100.99 
 
Table 3: Intra-day and inter-day precision and accuracy (n=5) 
Nominal 
concentration 
(ng/mL) 
Intra-day Inter-day 
 Found 
(ng/mL) 
Precision  
(% RSD) 
Accuracy  
(% recovery) 
Found 
(ng/mL) 
Precision  
(% RSD) 
Accuracy  
(% recovery) 
20 18.49 5.90 92.47 21.14 11.26 105.70 
50 44.24 7.75 88.49 52.64   8.45 105.28 
100 103.61 8.50 103.61 96.17   5.37   96.17 
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were 17.03 and 84.54%, respectively. The LLOQ value of 
this developed method was found to be 6 ng/mL, which 
corresponds to 0.12 ng in 20 µL of injection volume. 
Comparatively, considering the injection volumes, the 
LLOQs reported in literature were 1.25 ng33 2 ng10, 0.3 ng9 
obtained with HPLC UV-visible detection. Using an 
HPLC with a fluorescence detector, Schiborr et al. 
reported a higher sensitivity with an LLOQ of 0.2 ng12. A 
recent publication reported a lower LLOQ of curcumin in 
plasma obtained by LC-MS/MS detector at 0.1 ng34.  
Compared to the LLOQ values found by others who used 
different HPLC detectors, the current LLOQ value of 0.12 
ng obtained by our developed method achieves an 
excellent sensitivity, at which it is also comparable to the 
LLOQ value demonstrated by the analytical method 
employing an LC-MS/MS detector34. Apart from the 
LLOQ study, concentrations lower than 6 ng/mL were  
analyzed by the HPLC method, which were 0.5, 1.5, 3, and 
4 ng/mL. At the lowest concentration of 0.5 ng/mL, the  
curcumin peak was still detectable. However, quantitative 
determination of curcumin lower than 6 ng/mL is not 
recommended, because no linearity was observed between 
the ratios of the peak area of curcumin to that of IS and the 
curcumin concentration at the concentrations below 6 
ng/mL.  
Accuracy and precision 
Accuracy and precision data for intra-day and inter-day 
assay of spiked curcumin in plasma samples are presented 
in Table 3. The values of the assay for both intra- and inter-
day were found to be within the acceptable limits required 
by the FDA guidelines (Table 3). For all concentrations 
used in the accuracy and precision studies, the mean 
concentration value was within the 15% of the intended 
concentration (20, 50, and 100 ng/mL) with RSD values 
below 15%.  
Stability studies.   
Stability of curcumin in plasma samples was tested at two 
concentration levels, low and high concentration (20 and 
100 ng/mL) during (1) three freeze and thawing cycles, (2) 
storage at−20°C for 10 days, and (3) storage at room 
temperature for 4 h. In addition to that, post-preparation 
stability of curcumin at the concentrations of 20, 50, 200 
ng/mL was evaluated, by re-injection of the reconstituted 
samples after overnight placement in the HPLC 
autosampler at room temperature. The results of the 
stability studies are presented in Table 4. The deviation of 
the observed curcumin concentration from the nominal 
values was below 15% in all cases, demonstrating 
sufficient sample stability during these challenges. Based 
on the stability data, it can be concluded that (1) analysis 
of plasma samples is possible after at least three times 
freeze and thawing, (2) the time between blood sampling 
from the animal and analysis can be at least 10 days when 
stored at -20°C and (3) plasma samples can be stored at 
room temperature for 4 hours, the time necessary for 
sample preparation. Furthermore, reconstituted samples in 
methanol can be placed in the autosampler of the HPLC at 
least 10-12 hours before they are analyzed.    
Robustness study 
The deliberate changes applied in the operation parameters 
of the HPLC were column oven temperature (26, 30 °C) 
and flow rate 0.6, 0.8, and 1.0 mL/min. The change in 
column oven temperature did not affect the peak area and 
the tailing factor as demonstrated by the RSDs< 2%, 
however it exerted a substantial change in the peak 
retention time (RSD>2%). A small variation in the flow 
rate resulted variation in the peak area and peak retention 
time with an RSD>2%, while the tailing factor was not 
affected (RSD< 2%). For all the variations in the 
operational parameters in the developed analytical method, 
it is indicated that in general the peak performance was 
influenced by the small variation introduced in the 
equipment; however, the small variation in the column 
oven temperature only shifted the peak retention time. 
 
CONCLUSION 
Considering the quality of the chromatographic separation 
of the tested samples and the parameters that were 
validated in this study, the developed analytical method 
based on the RP-HPLC gradient mode has demonstrated as 
selective, precise, and accurate. The proposed method was 
found to be linear in the concentration range of 6-200 
ng/mL and considered to be highly selective with an 
LLOQ as low as 6 ng/mL. Qualitative detection of 
curcumin concentration in the plasma sample was possible 
at a concentration as low as 0.5 ng/mL. Stability studies 
demonstrates no significant degradation of curcumin in 
plasma samples during three freeze thawing cycles, storage 
at -20°C for 10 days, sample preparation and during 
storage of reconstituted samples overnight at ambient 
conditions. The robustness study shows that the deliberate 
change in the column oven temperature did not affect the 
Table 4: Stability studies of curcumin in rat plasma 
Studied items Nominal 
concentration 
(ng/mL) 
Found (ng/mL) Precision(%) Accuracy 
(%) 
Three freeze thawing cycles(n=3) 20 18.07 ± 1.19 6.57 90.35 
100 92.55 ± 2.09 2.25 92.55 
10 days storage in -20°C(n=3) 20 20.71±1.33 6.40 103.57 
100 92.55±2.09 2.25 92.55 
4 hr at room temperature(n=3) 20 19.77± 0.56 2.84 98.87 
100 97.07±4.26 4.39 97.07 
Autosampler  
(overnight)(n=5) 
20 21.20 ± 0.53 2.50 106.00 
50 46.07 ± 3.18 6.91 92.14 
200 208.59 ± 8.03 3.85 104.29 
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peak area and peak tailing factor. Therefore, the developed 
method is considered as applicable to accurately determine 
curcumin concentrations in plasma samples. 
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